Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | OMO-103 |
Trade Name | |
Synonyms | OMO 103|OMO103 |
Drug Descriptions |
OMO-103 inhibits MYC, potentially leading to decreased tumor cell proliferation (NCI Drug Dictionary). |
DrugClasses | c-MYC Inhibitor 12 |
CAS Registry Number | NA |
NCIT ID | C180503 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Gemcitabine + Nab-paclitaxel + OMO-103 | Gemcitabine Nab-paclitaxel OMO-103 | 0 | 1 |
OMO-103 | OMO-103 | 0 | 1 |